Source:http://linkedlifedata.com/resource/pubmed/id/13441770
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
13
|
pubmed:dateCreated |
1957-12-1
|
pubmed:keyword |
http://linkedlifedata.com/resource/pubmed/keyword/BISHYDROXYCOUMARIN/therapeutic use,
http://linkedlifedata.com/resource/pubmed/keyword/COUMARIN/related compounds,
http://linkedlifedata.com/resource/pubmed/keyword/ETHYL BISCOUMACETATE/therapeutic use,
http://linkedlifedata.com/resource/pubmed/keyword/THROMBOEMBOLISM/therapy
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
OM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0092-699X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
26
|
pubmed:volume |
32
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
342-9
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading | |
pubmed:year |
1957
|
pubmed:articleTitle |
Clinical experience with 3-(1-phenylpropyl)-4-hydroxycoumarin.
|
pubmed:publicationType |
Journal Article
|